NASHnext: A Noninvasive Test for Identifying Risk of NASH Disease Progression

被引：0
|
作者：
Hoffman, Ariel [1 ]
Chandler, Molly [1 ]
机构：
[1] Madigan Army Med Ctr, Joint Base Lewis Mcchord, WA 98431 USA
来源：
AMERICAN FAMILY PHYSICIAN | 2023年 / 108卷 / 04期
关键词：
DIAGNOSIS;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：408 / 410
页数：3
相关论文
共 50 条
  • [11] MACK-3: an accurate blood test for the diagnosis of fibrotic NASH and a candidate biomarker to monitor disease progression
    Canivet, Clemence
    Moal, Valerie
    Zuberbuhler, Floraine
    Adrien, Lannes
    Michalak, Sophie
    Roux, Marine
    Oberti, Frederic
    Fouchard, Isabelle
    Cales, Paul
    Boursier, Jerome
    JOURNAL OF HEPATOLOGY, 2020, 73 : S406 - S406
  • [12] Noninvasive risk stratification in unstable coronary artery disease: Exercise test and biochemical markers
    Lindahl, B
    Andren, B
    Ohlsson, J
    Venge, P
    Wallentin, L
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 : E40 - E44
  • [13] Identifying progression related disease risk modules based on the human subcellular signaling networks
    Xie, Ruiqiang
    Huang, Hao
    Li, Wan
    Chen, Binbin
    Jiang, Jing
    He, Yuehan
    Lv, Junjie
    Ma, Bo
    Zhou, Yanyan
    Feng, Chenchen
    Chen, Lina
    He, Weiming
    MOLECULAR BIOSYSTEMS, 2014, 10 (12) : 3298 - 3309
  • [14] Identifying Risk Factors for Progression of Rheumatoid Arthritis-Associated Interstitial Lung Disease
    Chaichian, Yashaar
    Bassiri, Dina
    Noth, Imre
    Strek, Mary
    Utset, Tammy
    Vij, Rekha
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [15] NONINVASIVE ASSESSMENT OF NASH/NAFLD BY THE FASTING 13C-GLUCOSE BREATH TEST
    Tanaka, Ken
    Matsuura, Tomokazu
    Nakada, Koji
    Tajiri, Hisao
    Suzuki, Masato
    HEPATOLOGY, 2011, 54 : 1170A - 1170A
  • [16] Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice
    Tsai, Hung-Cheng
    Chang, Fu-Pang
    Li, Tzu-Hao
    Liu, Chih-Wei
    Huang, Chia-Chang
    Huang, Shiang-Fen
    Yang, Ying-Ying
    Lee, Kuei-Chuan
    Hsieh, Yun-Cheng
    Wang, Ying-Wen
    Lee, Tzung-Yan
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    Lin, Han-Chieh
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [17] ASSOCIATION OF FIB4 SCORE WITH DISEASE PROGRESSION IN REAL-WORLD POPULATIONS DIAGNOSED WITH NAFLD/NASH OR AT RISK OF NASH IN US CLINICAL PRACTICE
    Lai, Michelle
    Broestl, Jeremy
    Frick, Andrew
    Haubrich, Richard
    Koch, Bruce
    Milligan, Scott
    Natha, Macky
    Younossi, Zobair M.
    Afdhal, Nezam H.
    GASTROENTEROLOGY, 2020, 158 (06) : S1416 - S1416
  • [18] Association of FIB-4 score with disease progression in real-world populations diagnosed with NAFLD/NASH or at risk of NASH in US clinical practice
    Lai, Michelle
    Broestl, Jeremy
    Frick, Andrew
    Haubrich, Richard
    Koch, Bruce
    Milligan, Scott
    Natha, Macky
    Younossi, Zobair
    Afdhal, Nezam
    JOURNAL OF HEPATOLOGY, 2020, 73 : S159 - S159
  • [19] Identifying modifiers of Huntington's disease progression
    Saft, Carsten
    LANCET NEUROLOGY, 2017, 16 (09): : 679 - 680
  • [20] Identifying Risk Factors for Disease Progression in Developmental Dysplasia of the Hip Using a Contralateral Hip Model
    Harris, Michael D.
    Thapa, Susan
    Lieberman, Elizabeth G.
    Pascual-Garrido, Cecilia
    Abu-Amer, Wahid
    Nepple, Jeffrey J.
    Clohisy, John C.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2024, 106 (24): : 2322 - 2329
12345